Related Experiment Videos
Elastin metabolism during perinatal lung development in the copper-deficient rat
Experimental Lung Research
|January 1, 1985
Summary
Copper deficiency and metal-chelating drugs like D-penicillamine (DPA) impair lung development in rats. These agents disrupt elastin metabolism and cross-linking, potentially affecting lung structure and function during alveolarization.
Area of Science:
- Biochemistry
- Developmental Biology
- Toxicology
Background:
- Copper (Cu) is essential for elastin metabolism.
- Alveolarization is a critical period for lung development.
- Metal-chelating drugs can interfere with copper homeostasis.
Purpose of the Study:
- To investigate the role of copper in rat lung elastin metabolism during alveolarization.
- To assess the impact of copper deficiency and metal-chelating drugs (D-penicillamine and triethylenetetramine) on lung development.
Main Methods:
- Pregnant rats were fed diets deficient in copper or supplemented with D-penicillamine (DPA) or triethylenetetramine (TETA).
- Lung tissue and liver copper levels were analyzed in pups at postnatal days 10 and 21.
- Elastin concentration, lysyl oxidase activity, and cross-linking amino acid distribution were measured.
Main Results:
- Copper deficiency and DPA treatment reduced lung elastin concentration and lysyl oxidase activity.
- Impaired elastin cross-linking was observed in copper-deficient and high-DPA groups.
- Morphological examination revealed airway dilation in these groups.
Conclusions:
- Copper deficiency and D-penicillamine (DPA) significantly impair lung elastin metabolism and cross-linking during development.
- These disruptions can lead to abnormal lung morphology, including airway dilation.
- Therapeutic doses of DPA and potentially TETA may pose risks to normal lung development.